Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Revolution Medicines, Inc.(RVMD) | 2,196,200 | 549,050 | -1,647,150 | $174.93M | $53.40M | 44.36% | -$121.53M |
| SailPoint, Inc.(SAIL) | 3,000,000 | 3,000,000 | 0 | $60.69M | $39.72M | 33.00% | -$20.97M |
| Lineage, Inc.(LINE) | 600,000 | 600,000 | 0 | $21.00M | $19.66M | 16.33% | -$1.34M |
| Neumora Therapeutics, Inc.(NMRA) | 2,124,143 | 2,124,143 | 0 | $3.80M | $4.14M | 3.44% | +$339.9K |
| Navan, Inc.CL A(NAVN) | 200,000 | 200,000 | 0 | $3.42M | $2.65M | 2.20% | -$768.0K |
| Revolution Medicines, Inc.W EXP 12 17 202(RVMD) | 450,000 | 450,000 | 0 | $423.0K | $805.5K | 0.67% | +$382.5K |